Updated safety analysis of cladribine tablets in the treatment of patients with multiple sclerosis

被引：0
|
作者：
Cook, S. [1 ]
Giovannoni, G. [2 ]
Leist, T. [3 ]
Syed, S. [4 ]
Nolting, A. [5 ]
Schick, R. [5 ]
机构：
[1] Rutgers State Univ, New Jersey Med Sch, Newark, NJ USA
[2] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England
[3] Thomas Jefferson Univ, Jefferson Med Coll, Div Clin Neuroimmunol, Philadelphia, PA 19107 USA
[4] EMD Serono Inc, Billerica, MA USA
[5] Merck KGaA, Darmstadt, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P875
引用
收藏
页码：465 / 466
页数：2
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS ANALYSIS OF CLADRIBINE TABLETS FOR TREATMENT OF PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN BULGARIA
    Djambazov, S.
    Slavchev, G.
    Dineva, T.
    Panayotov, P.
    Vekov, T.
    VALUE IN HEALTH, 2018, 21 : S206 - S206
  • [32] Integrated Lymphopenia Analysis in Younger and Older Patients With Multiple Sclerosis Treated With Cladribine Tablets
    Giovannoni, Gavin
    Coyle, Patricia K.
    Vermersch, Patrick
    Walker, Bryan
    Aldridge, Julie
    Nolting, Axel
    Galazka, Andrew
    Lemieux, Caroline
    Leist, Thomas P.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [33] Analysis of Lymphocyte Subsets in Younger and Older Patients with Multiple Sclerosis Treated with Cladribine Tablets
    Giovannoni, G.
    Coyle, P. K.
    Vermersch, P.
    Walker, B.
    Aldridge, J.
    Nolting, A.
    Galazka, A.
    Lemieux, C.
    Leist, T. P.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (1_SUPPL) : 44 - 44
  • [34] Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis
    Clavelou, Pierre
    Castelnovo, Giovanni
    Pourcher, Valerie
    De Seze, Jerome
    Vermersch, Patrick
    Ben-Amor, Ali-Frederic
    Savarin, Carine
    Defer, Gilles
    NEUROLOGY AND THERAPY, 2023, 12 (05) : 1457 - 1476
  • [35] Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis
    Pierre Clavelou
    Giovanni Castelnovo
    Valérie Pourcher
    Jerome De Sèze
    Patrick Vermersch
    Ali-Frederic Ben-Amor
    Carine Savarin
    Gilles Defer
    Neurology and Therapy, 2023, 12 : 1457 - 1476
  • [36] Reduction in grey matter atrophy in patients with relapsing multiple sclerosis following treatment with cladribine tablets
    Cortese, Rosa
    Battaglini, Marco
    Sormani, Maria Pia
    Luchetti, Ludovico
    Gentile, Giordano
    Inderyas, Maira
    Alexandri, Nektaria
    De Stefano, Nicola
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (01) : 179 - 186
  • [37] Safety and Efficacy of Intravenous Cladribine in Multiple Sclerosis Patients
    Alchaki, Abdul Rahman
    Anadani, Nidhiben
    Cook, Stuart
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 28 - 29
  • [38] Long-term experience with cladribine tablets in multiple sclerosis patients
    Oreja-Guevara, Celia
    Gomez Estevez, Irene
    Garcia Vasco, Lorena
    Quezada Sanchez, Johnny
    Diaz, Judit
    Gil-Perotin, Sara Garcia
    Alba Suarez, Elda Maria
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 966 - 966
  • [39] INTEGRATED SAFETY ANALYSIS; CLADRIBINE IN MULTIPLE SCLEROSIS (MS)
    Cook, Stuart
    Leist, Thomas
    Comi, Giancarlo
    Montalban, Xavier
    Sylvester, Elke
    Hicking, Christine
    Dangond, Fernando
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 : A49 - A49
  • [40] An analysis of malignancy risk in the clinical development programme of cladribine tablets in patients with relapsing multiple sclerosis
    Galazka, A.
    Nolting, A.
    Cook, S.
    Leist, T.
    Comi, G.
    Montalban, X.
    Hicking, C.
    Dangond, F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 133 - 133
12345